ESMO 2026 is being held in Madrid, Spain from 23 to 27 October. Credit: GlobalData Pancreatic cancer has historically presented a poor clinical outlook, offering patients few effective therapeutic options. Because the disease rarely causes early symptoms,... See more
MSD and Moderna have reported full Phase III results for their personalised cancer vaccine, but both companies' shares fell after some data points missed investor expectations. Unveiled early at the European Society of Medical Oncology (ESMO) 2026 confere... See more
The data leak led to Moderna and MSD's stocks both dropping on Thursday (22 October). Credit: Pixel-Shot / Shutterstock.com MSD and Moderna have reported full Phase III results for their personalised cancer vaccine, but both companies' shares fell after s... See more
A principal investigator (PI) holds ultimate site responsibility in multiple aspects, meaning document consideration is important. Credit: GlobalData. As clinical trial oversight has moved online as technology is more utilised in clinical trials, it bring... See more
The drug was previously refused for approval by the FDA. Credit: SeventyFour / Shutterstock.com Shionogi and F2G are releasing further data from a non-inferiority study of the latter's oral invasive aspergillosis drug, showing its promise in longer-term m... See more
